VWF and Stroke: Although drugs that target the inhibition of the action of VWF have not yet reached approval for the market (17), studies on FVIII/VWF levels during stroke and thrombolysis might provide useful descriptive data to understand the pathophysiology relevant to the potential clinical application of these inhibitors in the future in humans.